Biolex Therapeutics
closedBiolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.
Launch date
Employees
Market cap
-
Enterprise valuation
$80—120m (Dealroom.co estimates Oct 2010.)
Pittsboro North Carolina (HQ)
Authorizing premium user...